Psychedelics

Oregon’s initiative to legalize the medicinal use of psilocybin has officially qualified for the November ballot.

The U.S. Defense Advanced Research Projects Agency is funding a medical health study into the therapeutic use of psychedelics such as ketamine and psilocybin.

The latest documentary from streaming platform Netflix features celebrity interviews and re-enactments of psychedelic experiences alongside real information about psychotropic medicines. Have a Good Trip: Adventures in Psychedelics is a wonderfully built look at your brain on drugs — but in a good way.

Separate campaigns to legalize psilocybin therapy and to decriminalize all illegal drugs have teamed up in Oregon to gather signatures.

The Dr. Bronners soap company announced it has contributed $1 million to the psilocybin therapy legalization campaign in Oregon.

In celebration of the 4/20 holiday this month, we are using the whole month of April to focus on courageous cannabis and drug policy pioneers. Today, on what would have been his 89th birthday, we celebrate Baba Ram Dass, who helped legitimize the psychedelic revolution of the 1960s and awaken the public to the immorality of prohibition.

New York City-based Mind Medicine announced it had partnered with the world-leading psychedelics pharmacology and clinical research laboratory at University Hospital Basel in Switzerland.

A Vermont state lawmaker has pitched the decriminalization of three psychedelic substances — psilocybin, ayahuasca, and peyote — as well as kratom.

Scientists have created a bacteria solution that exudes industrial quantities of psilocybin, the psychedelic compound in “magic mushrooms” that is being studied as a potentially groundbreaking treatment for depression and other mental health afflictions.

Researchers at Johns Hopkins University announced last week the formation of what is likely the world’s largest research facility dedicated to psilocybin and psychedelic medicinal research.

Denver voters have passed a city initiative decriminalizing the adult possession and use of psilocybin (a.k.a. psychedelic) mushrooms. It is the first successful initiative of its kind in the U.S.